Avet-Loiseau, H., Goranova-Marinova, V., al., e. Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma,
, .
Avet-Loiseau, H., Goranova-Marinova, V., al., e. .
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.
: , .
Avet-Loiseau, H., Goranova-Marinova, V., al., e. ()
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma,
:
Avet-Loiseau, H.,
Goranova-Marinova, V., &
al., e.
().
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma. Blood; Blood.